New care bundle aims to keep transplant patients on track with lifesaving meds
NCT ID NCT07447388
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will develop and test a care bundle—a set of best practices—to help heart transplant patients stick to their immunosuppressive (anti-rejection) medication. The bundle will be created with input from patients and healthcare providers, then tested in 100 patients over 6 months. The goal is to standardize care and improve medication adherence, which is critical to prevent organ rejection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- immunosuppressive medication adherence care bundle (a set of evidence-based practices to improve medication adherence)
- What this could lead to
- If successful, this care bundle could become a standard tool to help transplant patients take their medications correctly, potentially reducing organ rejection and improving long-term health.
- What could go wrong
- This is a small, early-stage study (100 patients) testing a behavioral intervention, not a drug. It may not show a clear benefit, and results may not apply to all transplant patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSPLANT PATIENTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.